Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera

Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production

(2014) Mudassar Ahmad et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy

(2014) Roger Gilabert-Oriol et al.   CURRENT PHARMACEUTICAL DESIGN

The Many Spaces of uPAR: Delivery of Theranostic Agents and Nanobins to Multiple Tumor Compartments through a Single Target

(2013) Thomas V. O'Halloran et al.   Theranostics

Saporin-S6: A Useful Tool in Cancer Therapy

(2013) Letizia Polito et al.   Toxins

Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy

(2011) Maddalena de Virgilio et al.   CURRENT PHARMACEUTICAL DESIGN

Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients

(2011) Martin C. Boonstra et al.   CURRENT PHARMACEUTICAL DESIGN

Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy

(2011) Letizia Polito et al.   Toxins

Ribosome-Inactivating Proteins: From Plant Defense to Tumor Attack

(2010) Maddalena de Virgilio et al.   Toxins

The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

(2009) Salvatore Ulisse et al.   CURRENT CANCER DRUG TARGETS

Pichia pastoris as a host for secretion of toxic saporin chimeras

(2009) Alessio Lombardi et al.   FASEB JOURNAL

Evolving role of uPA/uPAR system in human cancers

(2008) Kathleen Dass et al.   CANCER TREATMENT REVIEWS